Pharmaceutical Contract Manufacturing Market Size, Share, and Analysis, By Molecule Type (Small Molecules, Large Molecules), By Service (Pharmaceutical Manufacturing Services, Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services, Drug Development Services, Biologic Manufacturing Services, Biologic API Manufacturing Services, Biologic FDF Manufacturing Services), By End User (Big Pharmaceutical Companies, Small & Mid-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users [Academic Institutes, Small CDMOs, and CROs]) and Regional Forecasts, 2022-2032.
Pharmaceutical Contract Manufacturing Market Size, Share, and Analysis, By Molecule Type (Small Molecules, Large Molecules), By Service (Pharmaceutical Manufacturing Services, Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services, Drug Development Services, Biologic Manufacturing Services, Biologic API Manufacturing Services, Biologic FDF Manufacturing Services), By End User (Big Pharmaceutical Companies, Small & Mid-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users [Academic Institutes, Small CDMOs, and CROs]) and Regional Forecasts, 2022-2032.
PRODUCT OVERVIEW
Pharmaceutical Contract Manufacturing Market size was USD 133.5 billion in 2021 and projected t%li%grow from USD 155.0 billion in 2023 t%li%USD 307.3 billion by 2032, exhibiting a CAGR of 7.9% during the forecast period.
Pharmaceutical Contract Manufacturing is the method by which pharmaceutical medications are made under the contract. In short, drug companies collaborate with a manufacturing business t%li%create a necessary quantity of their service or product and expedite production. A contract development and manufacturing organization (CDMO) manages all operations starting from pre-formulation as well as formulation development t%li%production and clinical trials, as opposed t%li%a contract manufacturing organization (CMO), which makes pre-formulated drugs.
MARKET HIGHLIGHTS
Pharmaceutical Contract Manufacturing market is expected t%li%reach USD 307.3 billion, growing at a CAGR of 7.9% during the forecast period owing t%li%factors like increasing research activities as well as investments in generic medications. Moreover, the significant price of in-house drug development and the regulatory filling support offered by CDMOs are propelling the expansion of the market.
Pharmaceutical Contract Manufacturing Market Segments:
Growth Drivers
Increasing Cases of Chronic Disorders worldwide is Expected t%li%Boost the Market Growth
Growing Research & Development in Pharmaceutical Manufacturing is Expected t%li%Boost the Market Growth
Restraint
Strict Government Regulatory Orders and their Controls t%li%Restrain the Market Growth
Key Players
Global Laboratory Temperature Control Units Market is further segmented by region into:
PRODUCT OVERVIEW
Pharmaceutical Contract Manufacturing Market size was USD 133.5 billion in 2021 and projected t%li%grow from USD 155.0 billion in 2023 t%li%USD 307.3 billion by 2032, exhibiting a CAGR of 7.9% during the forecast period.
Pharmaceutical Contract Manufacturing is the method by which pharmaceutical medications are made under the contract. In short, drug companies collaborate with a manufacturing business t%li%create a necessary quantity of their service or product and expedite production. A contract development and manufacturing organization (CDMO) manages all operations starting from pre-formulation as well as formulation development t%li%production and clinical trials, as opposed t%li%a contract manufacturing organization (CMO), which makes pre-formulated drugs.
MARKET HIGHLIGHTS
Pharmaceutical Contract Manufacturing market is expected t%li%reach USD 307.3 billion, growing at a CAGR of 7.9% during the forecast period owing t%li%factors like increasing research activities as well as investments in generic medications. Moreover, the significant price of in-house drug development and the regulatory filling support offered by CDMOs are propelling the expansion of the market.
Pharmaceutical Contract Manufacturing Market Segments:
- Molecule Type
- Small Molecules
- Large Molecules
- Service
- Pharmaceutical Manufacturing Services
- Pharmaceutical API Manufacturing Services
- Pharmaceutical FDF Manufacturing Services
- Drug Development Services
- Biologic Manufacturing Services
- Biologic API Manufacturing Services
- Biologic FDF Manufacturing Services
- End User
- Big Pharmaceutical Companies
- Small & Mid-Sized Pharmaceutical Companies
- Generic Pharmaceutical Companies
- Other End Users (Academic Institutes, Small CDMOs, and CROs)
Growth Drivers
Increasing Cases of Chronic Disorders worldwide is Expected t%li%Boost the Market Growth
Growing Research & Development in Pharmaceutical Manufacturing is Expected t%li%Boost the Market Growth
Restraint
Strict Government Regulatory Orders and their Controls t%li%Restrain the Market Growth
Key Players
- Therm%li%Fisher Scientific
- CR Pharmaceutical Group
- Boehringer Ingelheim Group
- AbbVie Contract Manufacturing
- WuXi App Tech.
- Dr. Reddy's Laboratories
- Lonza Group
- Catalent
- Recнpharm AB
- The Almac Group
- Curia Global
- Cambrex Corporation
- Carlyle Group
- Aenova Group GmbH
- Pfizer CentreOne
- Other Prominent Players
Global Laboratory Temperature Control Units Market is further segmented by region into:
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight int%li%the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1. Regional Market Share
1.2. Business Trends
1.3. Pharmaceutical Contract Manufacturing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Pharmaceutical Contract Manufacturing Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7. MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. MARKET ANALYSIS
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
9.1. Overview
9.2. Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
10.1. Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Molecule Type
10.3.1.1. Small Molecules
10.3.1.1.1. By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Large Molecules
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2. Market Share (%) 2022-2032F
10.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2. By Service
10.3.2.1. Pharmaceutical Manufacturing Services
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2. Market Share (%) 2022-2032F
10.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.2. Pharmaceutical API Manufacturing Services
10.3.2.2.1. By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3. Pharmaceutical FDF Manufacturing Services
10.3.2.3.1. By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.4. Drug Development Services
10.3.2.4.1. By Value (USD Million) 2022-2032F
10.3.2.4.2. Market Share (%) 2022-2032F
10.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.5. Biologic Manufacturing Services
10.3.2.5.1. By Value (USD Million) 2022-2032F
10.3.2.5.2. Market Share (%) 2022-2032F
10.3.2.5.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.6. Biologic API Manufacturing Services
10.3.2.6.1. By Value (USD Million) 2022-2032F
10.3.2.6.2. Market Share (%) 2022-2032F
10.3.2.6.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.7. Biologic FDF Manufacturing Services
10.3.2.7.1. By Value (USD Million) 2022-2032F
10.3.2.7.2. Market Share (%) 2022-2032F
10.3.2.7.3. Y-o-Y Growth (%) 2022-2032F
10.3.3. By End User
10.3.3.1. Big Pharmaceutical Companies
10.3.3.1.1. By Value (USD Million) 2022-2032F
10.3.3.1.2. Market Share (%) 2022-2032F
10.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.2. Small & Mid-Sized Pharmaceutical Companies
10.3.3.2.1. By Value (USD Million) 2022-2032F
10.3.3.2.2. Market Share (%) 2022-2032F
10.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.3. Generic Pharmaceutical Companies
10.3.3.3.1. By Value (USD Million) 2022-2032F
10.3.3.3.2. Market Share (%) 2022-2032F
10.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.4. Other End Users (Academic Institutes, Small CDMOs, and CROs)
10.3.3.4.1. By Value (USD Million) 2022-2032F
10.3.3.4.2. Market Share (%) 2022-2032F
10.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
11. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Molecule Type
11.3.2. By Service
11.3.3. By End User
11.4. Country
11.4.1. United States
11.4.2. Canada
12. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Molecule Type
12.3.2. By Service
12.3.3. By End User
12.4. Country
12.4.1. Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. ASIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Molecule Type
13.3.2. By Service
13.3.3. By End User
13.4. Country
13.4.1. India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Molecule Type
14.3.2. By Service
14.3.3. By End User
14.4. Country
14.4.1. Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Molecule Type
15.3.2. By Service
15.3.3. By End User
15.4. Country
15.4.1. Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. COMPETITIVE LANDSCAPE
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. COMPANY PROFILES
17.1. Thermo Fisher Scientific
17.1.1. Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4. Company Assessment
17.1.4.1. Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. CR Pharmaceutical Group
17.3. Boehringer Ingelheim Group
17.4. AbbVie Contract Manufacturing
17.5. WuXi App Tech.
17.6. Dr. Reddy's Laboratories
17.7. Lonza Group
17.8. Catalent
17.9. Recнpharm AB
17.10. The Almac Group
17.11. Curia Global
17.12. Cambrex Corporation
17.13. Carlyle Group
17.14. Aenova Group GmbH
17.15. Pfizer CentreOne
17.16. Other Prominent Players
18. APPENDIX
19. CONSULTANT RECOMMENDATION
1.1. Regional Market Share
1.2. Business Trends
1.3. Pharmaceutical Contract Manufacturing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Pharmaceutical Contract Manufacturing Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7. MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. MARKET ANALYSIS
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2. Economic
8.2.3. Social
8.2.4. Technological
9. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
9.1. Overview
9.2. Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
10.1. Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Molecule Type
10.3.1.1. Small Molecules
10.3.1.1.1. By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Large Molecules
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2. Market Share (%) 2022-2032F
10.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2. By Service
10.3.2.1. Pharmaceutical Manufacturing Services
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2. Market Share (%) 2022-2032F
10.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.2. Pharmaceutical API Manufacturing Services
10.3.2.2.1. By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3. Pharmaceutical FDF Manufacturing Services
10.3.2.3.1. By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.4. Drug Development Services
10.3.2.4.1. By Value (USD Million) 2022-2032F
10.3.2.4.2. Market Share (%) 2022-2032F
10.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.5. Biologic Manufacturing Services
10.3.2.5.1. By Value (USD Million) 2022-2032F
10.3.2.5.2. Market Share (%) 2022-2032F
10.3.2.5.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.6. Biologic API Manufacturing Services
10.3.2.6.1. By Value (USD Million) 2022-2032F
10.3.2.6.2. Market Share (%) 2022-2032F
10.3.2.6.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.7. Biologic FDF Manufacturing Services
10.3.2.7.1. By Value (USD Million) 2022-2032F
10.3.2.7.2. Market Share (%) 2022-2032F
10.3.2.7.3. Y-o-Y Growth (%) 2022-2032F
10.3.3. By End User
10.3.3.1. Big Pharmaceutical Companies
10.3.3.1.1. By Value (USD Million) 2022-2032F
10.3.3.1.2. Market Share (%) 2022-2032F
10.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.2. Small & Mid-Sized Pharmaceutical Companies
10.3.3.2.1. By Value (USD Million) 2022-2032F
10.3.3.2.2. Market Share (%) 2022-2032F
10.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.3. Generic Pharmaceutical Companies
10.3.3.3.1. By Value (USD Million) 2022-2032F
10.3.3.3.2. Market Share (%) 2022-2032F
10.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
10.3.3.4. Other End Users (Academic Institutes, Small CDMOs, and CROs)
10.3.3.4.1. By Value (USD Million) 2022-2032F
10.3.3.4.2. Market Share (%) 2022-2032F
10.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
11. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Molecule Type
11.3.2. By Service
11.3.3. By End User
11.4. Country
11.4.1. United States
11.4.2. Canada
12. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Molecule Type
12.3.2. By Service
12.3.3. By End User
12.4. Country
12.4.1. Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. ASIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Molecule Type
13.3.2. By Service
13.3.3. By End User
13.4. Country
13.4.1. India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Molecule Type
14.3.2. By Service
14.3.3. By End User
14.4. Country
14.4.1. Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. LATIN AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Molecule Type
15.3.2. By Service
15.3.3. By End User
15.4. Country
15.4.1. Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. COMPETITIVE LANDSCAPE
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. COMPANY PROFILES
17.1. Thermo Fisher Scientific
17.1.1. Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4. Company Assessment
17.1.4.1. Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. CR Pharmaceutical Group
17.3. Boehringer Ingelheim Group
17.4. AbbVie Contract Manufacturing
17.5. WuXi App Tech.
17.6. Dr. Reddy's Laboratories
17.7. Lonza Group
17.8. Catalent
17.9. Recнpharm AB
17.10. The Almac Group
17.11. Curia Global
17.12. Cambrex Corporation
17.13. Carlyle Group
17.14. Aenova Group GmbH
17.15. Pfizer CentreOne
17.16. Other Prominent Players
18. APPENDIX
19. CONSULTANT RECOMMENDATION
